Showing results (1-10 of 1,037) with videos related to
Sort By:
Pageof 104
Cell Reports. Medicine|August 8, 2025
Multiplexed iPSC platform for advanced NK cell immunotherapiesAkhilesh Kumar, Colin Fischer, Frank Cichocki, et al.The Journal of Clinical Investigation|April 16, 2019
Setting traps for NKG2A gives NK cell immunotherapy a fighting chanceFrank Cichocki, Jeffrey S MillerMethods in Molecular Biology (Clifton, N.J.)|December 25, 2009
In vitro development of human Killer-Immunoglobulin Receptor-positive NK cellsFrank Cichocki, Jeffrey S MillerJournal of Immunology (Baltimore, Md. : 1950)|August 21, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activityAkhilesh Kumar, Bin Zhang, Andrew Baldys, et al.Frontiers in Immunology|September 27, 2019
Human NK Cell Development: One Road or Many?Frank Cichocki, Bartosz Grzywacz, Jeffrey S MillerThe Journal of Allergy and Clinical Immunology|April 12, 2025
Chimeric antigen receptor therapies: Development, design, and implementationMadeline J Lee, Frank Cichocki, Jeffrey S MillerJournal of Innate Immunity|March 18, 2011
Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promotersFrank Cichocki, Jeffrey S Miller, Stephen K AndersonJournal of Leukocyte Biology|July 30, 2020
Unraveling exhaustion in adaptive and conventional NK cellsAimee M Merino, Hansol Kim, Jeffrey S Miller, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2023
NK Cells from Human Cytomegalovirus-Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR SignalingJohn R Lozada, Bin Zhang, Jeffrey S Miller, et al.Frontiers in Immunology|March 2, 2013
Epigenetic regulation of NK cell differentiation and effector functionsFrank Cichocki, Jeffrey S Miller, Stephen K Anderson, et al.Pageof 104